Oncologie is a distinguished academic journal published by WALTER DE GRUYTER GMBH, focusing on the dynamic and vital field of oncology. Established in 1999 and continuously published until 2024, this journal provides a platform for high-quality research and advancements in cancer treatment, prevention, and diagnosis. With an ISSN of 1292-3818 and an E-ISSN of 1765-2839, it is indexed in various databases, contributing to its growing visibility. Although categorized in the Q3 quartile for oncology research as of 2023, Oncologie offers essential insights and fosters scholarly dialogue among researchers, professionals, and students interested in oncology. Its unique contributions aim to bridge the gap between theoretical frameworks and clinical applications, making it a valuable resource for those seeking to advance their knowledge and expertise in cancer research.

The Journal of Integrative and Complementary Medicine, published by MARY ANN LIEBERT, INC, is at the forefront of exploring the interdisciplinary realms of complementary and alternative medicine. With its ISSN of 2768-3605 and E-ISSN 2768-3613, this prestigious journal has rapidly established itself as an essential resource for researchers, clinicians, and policymakers, evidenced by its Q1 ranking in Complementary and Alternative Medicine for 2023 and a Scopus rank of #31 out of 105 in this category. Spanning converged years from 2022 to 2024, the journal emphasizes rigorous research, innovative practices, and the integration of diverse healing modalities. As an open access journal, it provides readers with unparalleled access to high-quality studies, fostering collaboration and knowledge sharing in a field critical to holistic health approaches. The journal's commitment to advancing the understanding of integrative wellness is vital, particularly as healthcare continues to evolve and integrate various therapeutic practices.

Alternative Therapies in Health and Medicine is a distinguished peer-reviewed journal, published by InnoVision Professional Media, dedicated to advancing the field of complementary and alternative medicine. Since its inception in 1995, this journal has provided a platform for the dissemination of research focusing on holistic approaches to healthcare, innovative therapies, and integrative practices. With an ISSN of 1078-6791 and an E-ISSN of 1078-6791, it offers valuable insights crucial for researchers, healthcare professionals, and students alike. While the journal currently holds a Q3 ranking in both Complementary and Alternative Medicine and Miscellaneous Medicine categories as of 2023, it aims to foster an inclusive dialogue surrounding non-conventional medical practices and their integration into mainstream health paradigms. As the journal continues its journey through 2024, it remains steadfast in its objective to enrich academic discourse and promote evidence-based alternative therapies. Access to the journal is available through institutional subscriptions, enhancing its reach within the global academic community.

Journal of Holistic Nursing, published by SAGE Publications Inc., is a premier academic journal dedicated to the field of nursing, specializing in holistic approaches to health and care. With an impressive impact factor and ranked in the top tier as Q1 in Nursing (miscellaneous), this journal strives to advance the science and practice of holistic nursing by publishing high-quality research, comprehensive reviews, and innovative methodologies that enrich practitioners and educators alike. Spanning from 1983 to 2024, the journal serves as an invaluable resource for researchers, professionals, and students, promoting the dissemination of knowledge and fostering a multidisciplinary understanding of holistic health practices. With a Scopus rank of #7 out of 45 in its category, the Journal of Holistic Nursing plays a vital role in shaping the future of nursing education and practice.

The Chinese Journal of Natural Medicines, published by the esteemed CHINESE JOURNAL NATURAL MEDICINES, plays a pivotal role in the exploration and advancement of complementary and alternative medicine. With an ISSN of 2095-6975 and an E-ISSN of 1875-5364, this journal is recognized for its commitment to high-quality research and innovative findings in the realms of drug discovery and miscellaneous medical fields. Operating from China, it has earned a prestigious reputation in the academic community, achieving Q1 status in Complementary and Alternative Medicine and Q2 rankings in both Drug Discovery and Miscellaneous Medicine as of 2023, solidifying its influence within the scientific discourse. Researchers and professionals will find valuable insights here as the journal explores the intersection of traditional natural medicines with modern pharmacological science, making it an essential resource for anyone dedicated to the field. With a convergence period from 2004 to 2024, the journal continues to champion open dialogue and disseminate significant findings critical for the development of effective natural therapies.

World Journal of Gastrointestinal Oncology, published by BAISHIDENG PUBLISHING GROUP INC, stands as a pivotal resource in the evolving fields of gastroenterology and oncology, particularly focused on the intricate relationship between gastrointestinal disorders and cancer. Established in 2014, the journal continues to publish influential research, boasting a commendable Q2 ranking in both the gastroenterology and oncology categories for 2023, which underscores its importance in these critical medical domains. With a diverse range of topics and studies, it serves as an essential platform for researchers, healthcare professionals, and students aiming to stay informed about the latest advancements and innovations in gastrointestinal oncology. Though currently not classified as open access, the journal's rigorous peer-review process ensures the dissemination of high-quality research that significantly contributes to clinical practice and patient care. Its positioning in the Scopus rankings also highlights its competitive standing within the scientific community, fostering discussions that are crucial for advancing both fields. Explore the latest insights and findings to enhance your understanding and contribute to the ongoing dialogue in gastrointestinal health and oncology.

JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, published by Mary Ann Liebert, Inc., stands at the forefront of research in the field of Complementary and Alternative Medicine. With an ISSN of 1075-5535 and an E-ISSN of 1557-7708, this journal has been a pivotal source of scholarly articles since its inception in 1995, although its coverage in Scopus was discontinued in 2021. Renowned for its rigorous peer-review process and high-quality contributions, the journal ranks 23rd out of 93 in the Medicine-Complementary and Alternative Medicine category, firmly positioning it in the 75th percentile. Aimed at researchers, professionals, and students, the journal provides accessible insights into the interdisciplinary studies of alternative therapies and holistic health practices. With evolving open access options, it continues to disseminate crucial knowledge that can shape future therapeutic developments and influence healthcare practices. Explore the impactful content that can support and expand your understanding of complementary medicine at JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE.

SUPPORTIVE CARE IN CANCER is a premier academic journal published by Springer, dedicated to advancing the understanding and management of supportive care for cancer patients. With a notable impact factor, the journal is recognized for its contribution to the fields of Oncology, Rehabilitation, and Nursing, achieving impressive rankings in Scopus, including Q1 for Oncology Nursing and Rehabilitation, and Q2 for general Oncology. Founded in 1993 and looking towards a promising future until 2024, it serves as a vital resource for researchers, professionals, and students engaged in these critical areas of healthcare. Although not an Open Access journal, its rigorous peer-reviewed articles provide valuable insights into innovative practices and evidence-based strategies that enhance patient quality of life during and after treatment. By bridging the gap between research and clinical practice, SUPPORTIVE CARE IN CANCER significantly influences patient outcomes and fosters interdisciplinary collaboration in patient support.

European Journal of Integrative Medicine is a prestigious academic publication under the esteemed Elsevier Science Inc., dedicated to advancing knowledge in the field of Complementary and Alternative Medicine. With an ISSN of 1876-3820 and an E-ISSN of 1876-3839, this journal serves as a pivotal platform for researchers, professionals, and students alike, aiming to explore the integration of holistic practices with conventional medicine. With a Q2 ranking in the 2023 Scopus category for Complementary and Alternative Medicine, and a commendable percentile of 75th, the journal underscores its significance in fostering scholarly discourse and supporting innovative research from 2009 to 2024. The European Journal of Integrative Medicine does not currently offer open access options, encouraging subscription-based access that promotes the quality of published research. This journal is subsequently an essential resource for anyone seeking to deepen their understanding of integrative health approaches and their clinical applications in contemporary medicine.

ESMO Open is a premier open-access journal published by Elsevier, dedicated to advancing research in the fields of cancer and oncology. Since its inception in 2016, the journal has established itself as a vital resource for researchers, clinicians, and healthcare professionals, providing a platform for disseminating high-quality, peer-reviewed research. With an impressive Q1 ranking in both Cancer Research and Oncology based on the 2023 category quartiles, ESMO Open ranks within the top tier of its field, showcasing its commitment to excellence and innovation. The journal’s inclusion in Scopus rankings further emphasizes its significant impact, with remarkable placements in the 88th and 83rd percentiles for Oncology and Cancer Research, respectively. Operating under an open access model, ESMO Open ensures that cutting-edge findings and insights are readily available to the global academic community, fostering collaboration and knowledge-sharing to further enhance the understanding and treatment of cancer.